146 related articles for article (PubMed ID: 9529269)
1. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice.
Farrehi PM; Ozaki CK; Carmeliet P; Fay WP
Circulation; 1998 Mar; 97(10):1002-8. PubMed ID: 9529269
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.
Zhu Y; Carmeliet P; Fay WP
Circulation; 1999 Jun; 99(23):3050-5. PubMed ID: 10368124
[TBL] [Abstract][Full Text] [Related]
3. Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice.
Kawasaki T; Dewerchin M; Lijnen HR; Vermylen J; Hoylaerts MF
Blood; 2000 Jul; 96(1):153-60. PubMed ID: 10891445
[TBL] [Abstract][Full Text] [Related]
4. High concentrations of active plasminogen activator inhibitor-1 in porcine coronary artery thrombi.
Fay WP; Murphy JG; Owen WG
Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1277-84. PubMed ID: 8857925
[TBL] [Abstract][Full Text] [Related]
5. Vitronectin inhibits the thrombotic response to arterial injury in mice.
Fay WP; Parker AC; Ansari MN; Zheng X; Ginsburg D
Blood; 1999 Mar; 93(6):1825-30. PubMed ID: 10068653
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of plasminogen activator inhibitor-1 accelerates thrombolysis of a platelet-rich thrombus in rat mesenteric arterioles.
Rupin A; Martin F; Vallez MO; Bonhomme E; Verbeuren TJ
Thromb Haemost; 2001 Dec; 86(6):1528-31. PubMed ID: 11776323
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop.
Stringer HA; van Swieten P; Heijnen HF; Sixma JJ; Pannekoek H
Arterioscler Thromb; 1994 Sep; 14(9):1452-8. PubMed ID: 8068607
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice.
Konstantinides S; Schäfer K; Thinnes T; Loskutoff DJ
Circulation; 2001 Jan; 103(4):576-83. PubMed ID: 11157725
[TBL] [Abstract][Full Text] [Related]
9. PAI-1 inhibition enhances the lysis of the platelet-rich part of arterial-like thrombi formed in vitro. A comparative study using thrombi prepared from rat and human blood.
van Giezen JJ; Nerme V; Abrahamsson T
Blood Coagul Fibrinolysis; 1998 Jan; 9(1):11-8. PubMed ID: 9607114
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of fibrinolytic components play different roles in the formation and removal of arterial thrombus in mice.
Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
J Cardiovasc Pharmacol; 2002 Feb; 39(2):278-86. PubMed ID: 11791014
[TBL] [Abstract][Full Text] [Related]
11. The Fab-fragment of a PAI-1 inhibiting antibody reduces thrombus size and restores blood flow in a rat model of arterial thrombosis.
van Giezen JJ; Wahlund G; Nerme ; Abrahamsson T
Thromb Haemost; 1997 May; 77(5):964-9. PubMed ID: 9184411
[TBL] [Abstract][Full Text] [Related]
12. Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibody.
Biemond BJ; Levi M; Coronel R; Janse MJ; ten Cate JW; Pannekoek H
Circulation; 1995 Feb; 91(4):1175-81. PubMed ID: 7850956
[TBL] [Abstract][Full Text] [Related]
13. Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus.
Braaten JV; Handt S; Jerome WG; Kirkpatrick J; Lewis JC; Hantgan RR
Blood; 1993 Mar; 81(5):1290-9. PubMed ID: 8443390
[TBL] [Abstract][Full Text] [Related]
14. Potent Thrombolytic Effect of
Martinez de Lizarrondo S; Gakuba C; Herbig BA; Repessé Y; Ali C; Denis CV; Lenting PJ; Touzé E; Diamond SL; Vivien D; Gauberti M
Circulation; 2017 Aug; 136(7):646-660. PubMed ID: 28487393
[TBL] [Abstract][Full Text] [Related]
15. Induction of endothelial cell expression of the plasminogen activator inhibitor type 1 gene by thrombosis in vivo.
Fujii S; Sawa H; Saffitz JE; Lucore CL; Sobel BE
Circulation; 1992 Dec; 86(6):2000-10. PubMed ID: 1451272
[TBL] [Abstract][Full Text] [Related]
16. Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms.
Fay WP; Eitzman DT; Shapiro AD; Madison EL; Ginsburg D
Blood; 1994 Jan; 83(2):351-6. PubMed ID: 8286735
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice.
Carmeliet P; Moons L; Lijnen R; Janssens S; Lupu F; Collen D; Gerard RD
Circulation; 1997 Nov; 96(9):3180-91. PubMed ID: 9386191
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice.
Zhu Y; Farrehi PM; Fay WP
Circulation; 2001 Jun; 103(25):3105-10. PubMed ID: 11425776
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice.
Eitzman DT; Westrick RJ; Nabel EG; Ginsburg D
Blood; 2000 Jan; 95(2):577-80. PubMed ID: 10627465
[TBL] [Abstract][Full Text] [Related]
20. The mouse dorsal skinfold chamber as a model for the study of thrombolysis by intravital microscopy.
Boulaftali Y; Lamrani L; Rouzaud MC; Loyau S; Jandrot-Perrus M; Bouton MC; Ho-Tin-Noé B
Thromb Haemost; 2012 May; 107(5):962-71. PubMed ID: 22552380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
